Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis

Overview of attention for article published in Frontiers in Pharmacology, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 6,573 followers.

“The results strongly suggested that soybean effectively reduced AST and ALT levels to improve NAFLD-induced liver injury and reduce TG, TC, LDL, and FFA and upregulate HDL levels to improve lipid metabolism.Jan 10, 2023” https://t.co/yVYj5Uoc0Q

09 Sep 2023

Reply Repost Favourite

Frontiers | Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis https://t.co/yVYj5Uoc0Q

09 Sep 2023

Reply Repost Favourite

Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis https://t.co/4lPTCBc5Tu

11 Feb 2023

Reply Repost Favourite

Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis https://t.co/9bYFUlY0K2 https://t.co/7DThETE92l

10 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.